Nykode Therapeutics ASA Cash Flow Reinvestment Rate
Nykode Therapeutics ASA cash flow reinvestment rate. Nykode Therapeutics ASA (NYKD) has a Cash Flow Reinvestment Rate of 0.15x as of March 2022, reinvesting Nkr14.87 Million (capex Nkr14.06 Million plus investments Nkr817.00K) from operating cash flow of Nkr96.14 Million. Explore Nykode Therapeutics ASA debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Nykode Therapeutics ASA (2020–2021)
Cash flow reinvestment rate of Nykode Therapeutics ASA from 2020 to 2021. Historical reinvestment intensity for Nykode Therapeutics ASA across 2 annual periods. Explore Nykode Therapeutics ASA capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Nykode Therapeutics ASA Cash Flow Reinvestment Rate by Year (2020–2021)
Nykode Therapeutics ASA cash flow reinvestment rate by year from 2020 to 2021. Year-by-year capital reinvestment analysis for Nykode Therapeutics ASA. For the full cash flow conversion analysis, see NYKD operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 10.58x | Nkr12.22 Million | Nkr1.16 Million | Nkr871.00K | ▲ +31563.0% |
| 2020 | 0.03x | Nkr6.03 Million | Nkr180.27 Million | Nkr99.00K | — |